Author

C. Patel

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:proteomics· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

G. Z. Lederkremer· 2 shared M. Shenkman· 2 shared N. Ogen-Shtern· 2 shared B. Groisman· 1 shared B. L. Dunkerly-Eyring· 1 shared C. Chang· 1 shared D. A. Kass· 1 shared D. B. Henderson· 1 shared

Activity by Year

2022-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

G. Z. Lederkremer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Oligosaccharyltransferase is involved in targeting to ER-associated degradation

M. Shenkman, N. Ogen-Shtern, C. Patel, B. Groisman, M. Pasmanik-Chor, S. M. Schermann, R. Korner, G. Z. Lederkremer

The paper identifies oligosaccharyltransferase (OST) subunits as key interactors in ER-associated degradation (ERAD), suggesting a role in late stages of quality control beyond N-glycosylation.

bioRxiv · May 12, 2024 · PreprintCell Biology

Signaling Node at TSC2 S1365 Potently Regulates T-Cell Differentiation and Improves Adoptive Cellular Cancer Therapy

D. A. Kass, J. D. Powell, C. Patel, Y. Dong, B. L. Dunkerly-Eyring, J. Wen, M. J. Ranek, L. M. Bartle, D. B. Henderson, J. Sagert

This study shows that mutating TSC2 at S1365 enhances T-cell effector function and memory formation, improving adoptive T-cell therapy for cancer.

bioRxiv · Nov 30, 2022 · PreprintImmunology

COP I and II dependent trafficking controls ER-associated degradation in mammalian cells

N. Ogen-Shtern, C. Chang, H. Saad, N. Mazkereth, C. Patel, M. Shenkman, G. Z. Lederkremer

The paper investigates COPI and COPII-dependent trafficking in ERAD by tracking proteins in the ERQC and shows differential effects of inhibiting these pathways on retrotranslocation and ERAD.

bioRxiv · Apr 7, 2022Cell Biology